INVESTOR RIGHTS AGREEMENTInvestor Rights Agreement • January 17th, 2024 • Celularity Inc • Pharmaceutical preparations
Contract Type FiledJanuary 17th, 2024 Company IndustryThis Agreement is made pursuant to the Second Amended and Restated Loan Agreement, dated as of the date hereof, between the Company and Holder (the “Loan Agreement”).
INVESTOR RIGHTS AGREEMENTInvestor Rights Agreement • January 17th, 2024 • Celularity Inc • Pharmaceutical preparations
Contract Type FiledJanuary 17th, 2024 Company IndustryThis Investor Rights Agreement (this “Agreement”) is made and entered into as of January 12, 2024, between Celularity Inc., a Delaware corporation (the “Company”), and Dragasac Limited, a company incorporated in the Isle of Man (the “Holder”).